An asset write down of NZ$8.5 million (A$7.86m) saw New Zealand-based Rua Bioscience post a loss […]
Half-Year and Full-Year Financial Roundup: Rua Bioscience, Elixinol Wellness, Argent Biopharma, Wellnex Life, InhaleRx, Bioxyne
The Cannabis Observer
·
FOUNDING MEMBERS
First 100 readers lock in 50% off for life
Sector coverage written for operators, not tourists. Reserve founding-member pricing before launch.
- Weekday briefings on regulation, access schemes, and the companies shaping the market
- Full archive and weekly deep-dives once premium goes live
- 50% off the launch price, locked in for as long as your subscription stays active
Join 87 readers already on the waitlist
Argent BioPharma
Bioxyne
BLS
Elixinol Wellness
George Karafotias
InhaleRx
Paul Naske
Rua Bioscience
Wellnex Life
Related Articles
